For the Inventor, By the Inventor

Enter assignee name

Vancouver, Canada

Migenix, Inc.

USPTO Granted Patents = 20

EPO Patents = 1

Forward Citations = 62

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Soumitra S Ghosh (8 out of 58 patents)

Robert E Davis (7 out of 144 patents)

Yazhong Pei (6 out of 29 patents)

4. Christen M Anderson (6 out of 13 patents)

5. Tomas R Szabo (6 out of 8 patents)

6. William Christensen Clevenger (5 out of 10 patents)

7. Sandra Eileen Wiley (5 out of 7 patents)

8. Walter H Moos (4 out of 40 patents)

9. Radhakrishnan P Iyer (3 out of 37 patents)

10. Yi Jin (3 out of 23 patents)

11. Arlene Roland (3 out of 4 patents)

12. Wenqiang Zhou (3 out of 4 patents)

13. Scott W Miller (3 out of 6 patents)

14. Dale R Cameron (2 out of 27 patents)

15. Janet R Fraser (2 out of 7 patents)

20 patents: Sort by Forward Citations

1. 7709449 - Nucleic acid-based compounds and methods of use thereof (2010-05-04),

2. 7655623 - [object Object] (2010-02-02),

3. 7390787 - Compositions and methods for treating infections using analogues of indolicidin (2008-06-24),

4. 7309759 - Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics (2007-12-18),

5. 7304171 - Compounds and methods for cytoprotection (2007-12-04),

6. 7256179 - Nucleic acid-based compounds and methods of use thereof (2007-08-14),

7. 7230132 - Aryl N-cyanoguanidines and methods related thereto (2007-06-12),

8. 7138487 - Extractive purification of lipopeptide antibiotics (2006-11-21),

9. 7125844 - [object Object] (2006-10-24),

10. 7005274 - Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass (2006-02-28),

11. 7001729 - Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor (2006-02-21),

12. 6946261 - Efficient methods for producing anti-microbial cationic peptides in host cells (2005-09-20),

13. 6936638 - Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto (2005-08-30),

14. 6927218 - Aryl N-cyanoguanidines and methods related thereto (2005-08-09),

15. 6906175 - Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. (2005-06-14),

Migenix, Inc. is a leading biopharmaceutical company focused on developing innovative therapeutics for the treatment of infectious diseases. With a strong commitment to research and development, Migenix strives to address unmet medical needs and improve patient outcomes. Our experienced team of scientists and professionals work diligently to discover breakthrough treatments and bring them to market. Visit our website to learn more about our mission, pipeline, and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

20 Patents

#36 in Vancouver

#683 in Canada

#30,316 in the World

Vancouver, Canada

Migenix, Inc.

Forward Citations = 62

34 inventors:

Soumitra S Ghosh (8 out of 58 patents)

Robert E Davis (7 out of 144 patents)

Yazhong Pei (6 out of 29 patents)

4. Christen M Anderson (6 out of 13 patents)

5. Tomas R Szabo (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…